Antibody - International Biopharmaceutical Industry

news

Adcendo Raises $135m for Cancer ADCs, and Other Financings

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an oversubscribed second round that raised $13...

2 December 2024 news Adcendo | Antibody

Continue Reading →

Volume 5 Issue 3

ADCs – From Lab to Clinical Development

Antibody-drug conjugates (ADCs) are a family of targeted therapeutic agents for the treatment of cancer. Compared to traditional small-molecule approaches, ADCs offer...

12 October 2022 Volume 5 Issue 3 agents | Antibody

Continue Reading →

news

Early tests suggest Vir, GSK antibody could hold up versus omicron

Omicron's detection last week triggered travel restrictions and renewed public health measures around the world as scientists and government officials warned the vari...

3 December 2021 news Antibody | GSK

Continue Reading →

news

Regeneron warns its antibody drug may be less potent versus omicron

Regeneron's drug is the top-selling COVID-19 treatment in the U.S., one of three antibody drugs currently authorized by the Food and Drug Administration for people wh...

3 December 2021 news Antibody | COVID-19

Continue Reading →

news

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picod...

2 November 2021 news Antibody | cell screening

Continue Reading →

news

US stocks up on COVID-19 antibody drugs amid shortage concerns

The antibody treatments from Regeneron and Eli Lilly have been proven effective in reducing the risk of hospitalization or death from COVID-19 in certain high-risk in...

17 September 2021 news Antibody | bamlanivimab

Continue Reading →